What was the main announcement regarding the Remuneration Committee?

The company announced the appointment of new members to its Remuneration Committee.

When did the changes to the Remuneration Committee take effect?

The changes took effect on May 15, 2026.

AI News NQ Analysis

Polaris Pharmaceuticals-KY Announces Remuneration Committee Member Appointments

NQ Score 50/100

AI Summary (NQ-processed)

Polaris Pharmaceuticals-KY (6550) announced on May 15, 2026, that its board of directors has resolved to appoint new members to the Remuneration Committee. This change follows the comprehensive re-election of directors, including independent directors, at the company's 2026 annual general meeting. The previous committee members' terms have expired. The newly appointed members are Zhao Yingcheng, Di Shijie (Associate Professor at the University of Hong Kong), and Zhang Zhigang (CEO of Zhongen Biomedical). The effective date for the new appointments is May 15, 2026.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the company code for Polaris Pharmaceuticals-KY?: A: The company code is 6550.
Q: What was the main announcement regarding the Remuneration Committee?: A: The company announced the appointment of new members to its Remuneration Committee.
Q: When did the changes to the Remuneration Committee take effect?: A: The changes took effect on May 15, 2026.
Q: Why were there changes in the Remuneration Committee?: A: The changes were due to the completion of the previous term and the comprehensive re-election of directors, including independent directors, at the 2026 annual general meeting.